CJC-1295 DAC is a synthetic growth hormone-releasing hormone (GHRH) analog engineered with a Drug Affinity Complex to extend its biological half-life. In non-clinical scientific research, understanding the regulatory status and compliance guidelines surrounding CJC-1295 DAC is essential for institutional procurement and protocol design. PX1 Research supplies high-purity research compounds strictly for in vitro and preclinical laboratory applications.
CJC-1295 DAC is a synthetic growth hormone-releasing hormone (GHRH) analog engineered with a Drug Affinity Complex to extend its biological half-life. In non-clinical scientific research, understanding the regulatory status and compliance guidelines surrounding CJC-1295 DAC is essential for institutional procurement and protocol design. PX1 Research supplies high-purity research compounds strictly for in vitro and preclinical laboratory applications.
To address whether CJC-1295 DAC legal status permits acquisition, the compound is fully legal to purchase, possess, and evaluate within the United States for non-human laboratory research, biochemical assays, and preclinical experimental protocols. It is classified as an investigational chemical reagent rather than a scheduled controlled substance, meaning academic, institutional, and private laboratories can lawfully acquire it without a DEA registration.
However, because CJC-1295 DAC is not approved by the U.S. Food and Drug Administration (FDA) for human administration, diagnosis, or therapeutic use, vendors must sell it strictly under a research-use-only (RUO) designation. Researchers looking to buy the CJC-1295 DAC peptide must verify that suppliers adhere to strict compliance parameters, ensuring products are labeled, documented, and distributed exclusively for in vitro and animal research models.
CJC-1295 DAC is a 30-amino-acid tetrasubstituted peptide derivative of natural GHRH (1-29). The defining structural modification of this compound is the addition of a maleimido-propionic acid linker covalently attached to the Lys30 residue, forming the Drug Affinity Complex (DAC).
In preclinical models, this reactive maleimide moiety forms a stable covalent bond with endogenous serum albumin following exposure. Because serum albumin exhibits an extended half-life in circulating biofluids, the conjugated peptide resists rapid renal clearance and enzymatic degradation by dipeptidyl peptidase IV (DPP-IV). This prolongs the biological half-life of the compound from several minutes to multiple days, enabling continuous activation of pituitary GHRH receptors in laboratory settings.
In vitro assays and rodent models demonstrate that CJC-1295 DAC selectively binds to the growth hormone-releasing hormone receptor (GHRHR) on anterior pituitary somatotrophs. This binding cascade stimulates the pulsatile synthesis and release of endogenous growth hormone (GH), which subsequently triggers hepatic transcription of insulin-like growth factor 1 (IGF-1).
Because of its extended duration of action, researchers utilize CJC-1295 DAC to study sustained growth factor elevation without requiring frequent administration in longitudinal protocols. Key investigative areas include cellular proliferation, tissue repair mechanics, protein translation efficiency, and metabolic substrate partitioning in animal models. Further research documentation can be found within our comprehensive research peptides library.
When evaluating if cjc 1295 dac legal guidelines are met during institutional purchasing, principal investigators must ensure their organization uses the material in accordance with local, state, and federal laws. Research compounds supplied under RUO status cannot be repurposed for clinical trials, compounding pharmacy formulations, or human consumption.
Legitimate scientific vendors enforce strict qualification standards prior to fulfilling orders. Buyers operating under laboratory wholesale accounts or institutional grants are expected to maintain appropriate bio-containment equipment, standard operating procedures, and disposal protocols suitable for synthetic peptides.
In physiological and biochemical research, comparative studies frequently evaluate CJC-1295 DAC alongside short-acting analogs to observe kinetic differences in receptor engagement. For example, comparing the sustained profile of CJC-1295 DAC against CJC-1295 without DAC demonstrates how the maleimide linker alters serum persistence and receptor desensitization thresholds.
Furthermore, researchers often benchmark these GHRH derivative compounds against other secretagogues within the same pathway. A standard experimental matrix may contrast CJC-1295 DAC with Sermorelin, a truncated 29-amino-acid GHRH fragment, or Tesamorelin, a stabilized GHRH analog featuring a hexenoic acid modification. Additionally, researchers studying synergistic GH release frequently pair GHRH analogs with ghrelin receptor agonists like Ipamorelin in preclinical dual-agonist models. Detailed comparative overviews are detailed in our guide on GHRH analog mechanisms.
To ensure reproducible experimental outcomes, research reagents must undergo rigorous analytical verification. PX1 Research subjects every batch of CJC-1295 DAC to a multi-tiered quality control pipeline in ISO 17025 accredited, GMP-compliant facilities within the USA.
Analytical standards require high-performance liquid chromatography (RP-HPLC) to confirm peptide purity exceeding 99%, accompanied by electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular weight structure. Crucially, lot-specific Certificate of Analysis (COA) documents verify that bacterial endotoxin levels remain below strict thresholds (<0.01 EU/mg), eliminating confounding inflammatory variables in cell culture and animal research. Learn more about evaluating analytical documentation in our resource on peptide purity and HPLC analysis.
Obtaining research reagents from domestic manufacturers minimizes risk, ensures chain-of-custody security, and guarantees chemical integrity. PX1 Research adheres to rigorous manufacturing and distribution standards tailored to academic and industrial scientific needs:
• USA-Manufactured & Formulated: Produced in domestic GMP-compliant facilities under strict quality parameters. • Lot-Specific Third-Party COA: Every shipped batch includes independent, verifiable HPLC and Mass Spectrometry data. • Endotoxin Tested: Assayed to confirm minimal endotoxin content for sensitive cell assays and animal models. • Rapid Fulfillment: Orders ship same-day (Monday–Friday) directly from our CA and AZ distribution centers. • Fully Traceable Batches: Full lot tracking ensures identity and stability from synthesis to laboratory bench.
Lyophilized CJC-1295 DAC powder must be stored in temperature-controlled conditions to prevent hydrolytic degradation. Upon receipt, lyophilized vials should be kept at -20°C for short-term preservation or -80°C for long-term storage in sealed, desiccant-equipped containers.
Reconstitution for in vitro application should be conducted inside a laminar flow hood using sterile Bacteriostatic Water or sterile 0.9% Sodium Chloride, depending on assay protocol constraints. Diluent should be introduced along the glass vial wall to prevent mechanical shear stress on the peptide chain. Once reconstituted, liquid aliquots should be maintained at 2°C to 8°C and utilized within an established stability window to prevent enzymatic decay or aggregation.
Is cjc-1295 dac legal to buy for laboratory research in the US?
Yes, CJC-1295 DAC is fully legal to purchase and possess in the United States for non-clinical laboratory research, in vitro experiments, and scientific assays. It is an unregulated research chemical and not a scheduled controlled substance.
What is the regulatory status of cjc 1295 dac legal compliance for academic institutions?
CJC-1295 DAC is designated for Research Use Only (RUO). Academic institutions and private laboratories can lawfully acquire and utilize it provided it is not administered to humans or used in clinical applications.
How does CJC-1295 with DAC differ from CJC-1295 without DAC in preclinical research?
CJC-1295 with DAC contains a maleimido-propionic acid linker that binds to serum albumin, extending its biological half-life to several days in animal models. CJC-1295 without DAC lacks this complex and exhibits a significantly shorter half-life of 30 to 60 minutes.
What analytical testing methods verify the purity of CJC-1295 DAC?
Purity is verified through Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chemical purity and Mass Spectrometry (MS) for exact molecular weight confirmation. Endotoxin testing via LAL assay is also performed.
What are the recommended storage conditions for lyophilized CJC-1295 DAC?
Lyophilized CJC-1295 DAC should be stored dry at -20°C or -80°C away from light and moisture. Under these cold storage conditions, the peptide remains stable for extended periods.
How should research laboratories reconstitute CJC-1295 DAC for in vitro assays?
Reconstitution should occur in a sterile environment using sterile laboratory solvents such as Bacteriostatic Water. The solvent should be gently dripped down the side of the vial to minimize structural agitation.
Is CJC-1295 DAC considered a controlled substance under federal law?
No, CJC-1295 DAC is not listed on any Controlled Substances Act (CSA) schedules. It remains an unregulated non-clinical investigational compound.
Why is endotoxin testing critical for CJC-1295 DAC research reagents?
Bacterial endotoxins can induce inflammatory reactions in cell cultures or animal models, distorting experimental results. High-quality research peptides require endotoxin testing (<0.01 EU/mg) to ensure data validity.
Can principal investigators set up institutional bulk accounts for peptide procurement?
Yes, qualified research organizations, academic institutions, and commercial laboratories can open institutional wholesale accounts with PX1 Research for bulk quantities and verified lot supply.
What shipping timelines apply to research peptide orders from PX1 Research?
PX1 Research dispatches orders same-day Monday through Friday from facilities in California and Arizona to minimize transit time and protect chemical stability.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.